The Gross Law Firm has issued a shareholder alert for a securities class action lawsuit against ADMA Biologics, Inc. The class period runs from August 9, 2024 to March 25, 2026, with a lead plaintiff deadline of August 10, 2026. The complaint alleges that the company made false and misleading statements and failed to disclose an undisclosed related party transaction, the use of channel stuffing to inflate revenue, and a lack of adequate internal controls. Shareholders who purchased ADMA shares during the class period and suffered losses are encouraged to register for the case.
ADMA Biologics IncSecurities class action lawsuit alleging false statements, undisclosed related party transaction, channel stuffing, and inadequate internal controls.